|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000016776 |
| Receipt No. | R000019460 |
| Scientific Title | A phase III, randomized, controlled study of mFOLFOX6 + bevacizumab combination therapy versus mFOLFOX6 + panitumumab combination therapy in chemotherapy-naive patients with KRAS/NRAS wild-type, incurable/unresectable, advanced/recurrent colorectal cancer |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2017/06/14 19:05:53 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2015/03/11 17:07:04 | ||
| 2 | Update | 2015/03/24 10:16:19 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 3 | Update | 2015/03/24 10:20:46 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 4 | Update | 2015/03/24 10:25:35 | Email |
|
| 5 | Update | 2015/06/16 12:08:17 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2015/06/16 12:09:07 | Recruitment status |
|
| 7 | Update | 2016/09/12 09:02:01 | Key exclusion criteria |
|
| 8 | Update | 2016/09/12 09:03:45 | Name of primary sponsor Organization |
|
| 9 | Update | 2017/06/14 19:05:53 | Recruitment status |
